Avillion Chooses BSI’s eClinical Software for its Clinical Operations
BSI announces that it has been awarded the contract for the supply of its Clinical Trial Management System (CTMS) to Avillion LLP. Avillion is a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through to regulatory approval.
Avillion selected the BSI CTMS as they felt it met their objectives of being a modular solution across a broad range of functions required to manage and oversee large and complex trial programs. In addition, the platform provides a flexible solution with a high level of configuration without the need for programming, facilitating optimal support of business needs in the evolving clinical research environment. BSI CTMS also comes with fully integrated eTMF and LMS modules, avoiding the need for clients to purchase and integrate other solutions.
"Being a small company, it was essential for us to be able to find a system that was flexible and met our needs, but was also quick and simple to implement and maintain in-house. Having worked closely with BSI to implement the system, we are delighted with the ease at which we have been able to incorporate the BSI CTMS system into our working practices”.
Next Best Action:
BSI Life Sciences
Community Manager Life Sciences
+41 58 255 96 22